The EAP process provides ...
“access to an investigational medical product for treatmentoutside of clinical trials when no comparable or satisfactory alternativetherapy options are available. “
My emphasis added.
This is stating very clearly that there are no comparable orsatisfactory alternative therapy options available – MSB is it !!! There are no others at this stage.
So please tell me why MSB is not the treatment about to beannounced.
The EAP process provides ...“access to an investigational...
-
- There are more pages in this discussion • 370 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |